Osteoarthritis (OA) is a highly prevalent whole-joint disease that causes disability and pain
and affects a patient's quality of life. However, currently, there is a lack of effective early …

Osteoarthritis (OA) is a chronic degenerative disorder of the joint and its prevalence and
severity is increasing owing to ageing of the population. Osteoarthritis is characterized by …

Osteoarthritis (OA) is a chronic joint disease characterized by inflammation, gradual
destruction of articular cartilage, joint pain, and functional limitations that eventually lead to …

Extracellular vesicles (EVs) are nanoscale particles secreted by almost all cell types to
facilitate intercellular communication. Stem cell-derived EVs theoretically have the same …

Osteoarthritis (OA) is a common degenerative disease that can lead to persistent pain and
motion restriction. In the last decade, stem cells, particularly mesenchymal stem cells …

Rheumatoid arthritis (RA) is a heterogeneous autoimmune disorder that leads to severe joint
deformities, negatively affecting the patient's quality of life. Extracellular vesicles (EVs) …

Osteoarthritis (OA) is a prevalent whole joint disease characterised by cartilage degradation,
subchondral bone sclerosis and bone remodelling, and synovium inflammation, leading to …

Cell-derived extracellular vesicles (EVs), present in synovial fluid and cartilage extracellular
matrix (ECM), are involved in joint development and in the regulation of joint homeostasis …

Secretome and extracellular vesicles (EVs) are considered a promising option to exploit
mesenchymal stem cells'(MSCs) properties to address knee osteoarthritis (OA). The aim of …

Extracellular vesicles (EVs) have therapeutic effects on osteoarthritis (OA). Some recent
strategies could elevate EV's therapeutic properties including cell aggregation, co-culture …